Fibroblast growth factor 21 in metabolic syndrome.


Journal

Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782

Informations de publication

Date de publication:
2023
Historique:
received: 10 05 2023
accepted: 11 07 2023
medline: 15 8 2023
pubmed: 14 8 2023
entrez: 14 8 2023
Statut: epublish

Résumé

Metabolic syndrome is a complex metabolic disorder that often clinically manifests as obesity, insulin resistance/diabetes, hyperlipidemia, and hypertension. With the development of social and economic systems, the incidence of metabolic syndrome is increasing, bringing a heavy medical burden. However, there is still a lack of effective prevention and treatment strategies. Fibroblast growth factor 21 (FGF21) is a member of the human FGF superfamily and is a key protein involved in the maintenance of metabolic homeostasis, including reducing fat mass and lowering hyperglycemia, insulin resistance and dyslipidemia. Here, we review the current regulatory mechanisms of FGF21, summarize its role in obesity, diabetes, hyperlipidemia, and hypertension, and discuss the possibility of FGF21 as a potential target for the treatment of metabolic syndrome.

Identifiants

pubmed: 37576954
doi: 10.3389/fendo.2023.1220426
pmc: PMC10414186
doi:

Substances chimiques

fibroblast growth factor 21 0
Fibroblast Growth Factors 62031-54-3

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1220426

Informations de copyright

Copyright © 2023 Yang, Liu, Jiang, Liu, Luo, Li, Zhao, Han, Chen, Li, Xiao and Sun.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Trends Endocrinol Metab. 2015 Nov;26(11):608-617
pubmed: 26490383
J Cell Mol Med. 2015 Jul;19(7):1557-68
pubmed: 25823710
Cell Metab. 2013 May 7;17(5):779-89
pubmed: 23663741
Clin Chem. 2017 Jul;63(7):1261-1270
pubmed: 28606915
J Biol Chem. 2006 Jun 9;281(23):15694-700
pubmed: 16597617
Metab Syndr Relat Disord. 2021 Nov;19(9):491-497
pubmed: 34448598
Vitam Horm. 2016;101:17-58
pubmed: 27125737
Cardiovasc Diabetol. 2013 Aug 28;12:124
pubmed: 23981342
Exp Cell Res. 2020 Aug 15;393(2):112108
pubmed: 32445748
Acta Biomater. 2021 Aug;130:395-408
pubmed: 34129954
Theranostics. 2023 Jan 22;13(3):1076-1090
pubmed: 36793871
Nutrients. 2020 Jul 18;12(7):
pubmed: 32708435
J Biochem. 2011 Feb;149(2):121-30
pubmed: 20940169
Proc Natl Acad Sci U S A. 2019 Apr 16;116(16):7819-7824
pubmed: 30944224
Free Radic Biol Med. 2016 Apr;93:94-109
pubmed: 26849944
Diabetes. 2021 Oct 21;:
pubmed: 34675003
Sci Transl Med. 2012 Nov 28;4(162):162ra153
pubmed: 23197570
BMC Biotechnol. 2017 Jul 4;17(1):58
pubmed: 28676059
Cell Metab. 2018 Jun 05;27(6):1323-1337.e5
pubmed: 29706566
Int J Endocrinol. 2019 Sep 10;2019:5163245
pubmed: 31582974
J Mol Cell Cardiol. 2022 Sep;170:22-33
pubmed: 35661620
Front Endocrinol (Lausanne). 2020 Dec 22;11:601349
pubmed: 33414764
PLoS One. 2022 Aug 25;17(8):e0273527
pubmed: 36006939
J Biol Chem. 2013 Apr 12;288(15):10490-504
pubmed: 23430257
Cell Metab. 2016 Mar 8;23(3):427-40
pubmed: 26959184
J Healthc Eng. 2022 Feb 22;2022:6777771
pubmed: 35242298
Carcinogenesis. 2009 Jun;30(6):1024-31
pubmed: 19386581
Cell Metab. 2013 May 7;17(5):790-7
pubmed: 23663742
EMBO Mol Med. 2018 Aug;10(8):
pubmed: 29987000
FASEB J. 2005 Jul;19(9):1061-6
pubmed: 15985529
Nutrients. 2022 Sep 21;14(19):
pubmed: 36235573
Signal Transduct Target Ther. 2020 Sep 2;5(1):181
pubmed: 32879300
Cell Metab. 2007 Jun;5(6):415-25
pubmed: 17550777
Cell Death Dis. 2018 Feb 14;9(2):227
pubmed: 29445083
Biochem Biophys Res Commun. 2019 Dec 3;520(2):459-465
pubmed: 31607484
J Diabetes Investig. 2021 Aug;12(8):1322-1325
pubmed: 33316144
J Biol Chem. 2010 May 21;285(21):15668-73
pubmed: 20332535
Front Endocrinol (Lausanne). 2015 Nov 05;6:168
pubmed: 26594197
Int J Clin Exp Pathol. 2020 Feb 01;13(2):220-229
pubmed: 32211102
Nat Rev Nephrol. 2019 Jan;15(1):27-44
pubmed: 30455427
J Physiol Biochem. 2019 Jun;75(2):229-240
pubmed: 30927227
J Diabetes Res. 2021 Oct 08;2021:3715026
pubmed: 34660809
J Nutr Biochem. 2018 Jul;57:189-196
pubmed: 29751292
J Mol Cell Biol. 2016 Apr;8(2):110-9
pubmed: 26993043
Pharmacol Rev. 2006 Dec;58(4):712-25
pubmed: 17132850
Ann Transl Med. 2020 Mar;8(6):310
pubmed: 32355754
Cancer Lett. 2021 Feb 28;499:5-13
pubmed: 33264641
Toxicol Appl Pharmacol. 2010 Jun 15;245(3):326-34
pubmed: 20350562
Chronic Dis Transl Med. 2022 Feb 23;8(1):19-25
pubmed: 35620160
J Clin Invest. 2006 Jul;116(7):1784-92
pubmed: 16823476
Theranostics. 2020 Aug 7;10(22):9923-9936
pubmed: 32929325
J Nutr. 2022 Apr 1;152(4):926-938
pubmed: 34958390
Can J Physiol Pharmacol. 2022 Sep 1;100(9):937-944
pubmed: 35820184
Am J Transl Res. 2016 Dec 15;8(12):5309-5319
pubmed: 28078004
Am J Transl Res. 2017 Dec 15;9(12):5299-5307
pubmed: 29312484
Nat Rev Drug Discov. 2007 Oct;6(10):793-810
pubmed: 17906642
Antioxid Redox Signal. 2018 Dec 10;29(17):1727-1745
pubmed: 28899199
Clin Endocrinol (Oxf). 2014 Jan;80(1):57-64
pubmed: 23278761
Heart Fail Rev. 2023 Jan;28(1):261-272
pubmed: 36028609
Obesity (Silver Spring). 2019 Jan;27(1):41-49
pubmed: 30520566
Biomed Res Int. 2021 Jul 8;2021:1497449
pubmed: 34307650
Biomed Res Int. 2014;2014:807874
pubmed: 24900988
Biosci Biotechnol Biochem. 2016 May;80(5):929-34
pubmed: 27010621
J Clin Endocrinol Metab. 2009 Sep;94(9):3594-601
pubmed: 19531592
Mol Endocrinol. 2008 Apr;22(4):1006-14
pubmed: 18187602
J Cell Mol Med. 2019 Feb;23(2):1059-1071
pubmed: 30461198
Korean J Physiol Pharmacol. 2022 Sep 1;26(5):347-355
pubmed: 36039735
Endocrinology. 2008 Dec;149(12):6018-27
pubmed: 18687777
Diabetes. 2011 Oct;60(10):2465-73
pubmed: 21852674
Nat Med. 2013 Jan;19(1):83-92
pubmed: 23202295
J Hepatol. 2018 Oct;69(4):896-904
pubmed: 29886156
Cell Metab. 2008 Aug;8(2):169-74
pubmed: 18680716
Biochim Biophys Acta Mol Basis Dis. 2019 Jun 1;1865(6):1241-1252
pubmed: 30677512
Cell Metab. 2016 Mar 8;23(3):441-53
pubmed: 26853749
Circ Res. 2019 Apr 12;124(8):1160-1162
pubmed: 30973809
J Clin Endocrinol Metab. 2022 Jan 1;107(1):e57-e70
pubmed: 34431493
Cell Metab. 2014 Oct 7;20(4):670-7
pubmed: 25130400
Endocrinology. 2014 Aug;155(8):2924-31
pubmed: 24885573
Nat Metab. 2022 May;4(5):608-626
pubmed: 35551509
Cell Rep Med. 2020 Jul 21;1(4):100057
pubmed: 33205064
Elife. 2023 Jan 17;12:
pubmed: 36648330
Endocr Rev. 2017 Oct 1;38(5):468-488
pubmed: 28938407
PLoS One. 2013 Jun 18;8(6):e65763
pubmed: 23823755
Med Res Rev. 2016 Jul;36(4):672-704
pubmed: 27031294
Circulation. 2022 Nov 15;146(20):1537-1557
pubmed: 36134579
Arterioscler Thromb Vasc Biol. 2013 Oct;33(10):2454-9
pubmed: 23887638
Expert Rev Clin Pharmacol. 2021 Oct;14(10):1233-1252
pubmed: 34591728
Gut. 2021 Oct;70(10):1933-1945
pubmed: 33177163
Br J Pharmacol. 2020 Aug;177(16):3760-3777
pubmed: 32446270
Annu Rev Physiol. 2016;78:223-41
pubmed: 26654352
Cell Metab. 2010 Mar 3;11(3):206-12
pubmed: 20197053
Biomed J. 2022 Jul 16;46(4):100548
pubmed: 35850479
Mol Neurobiol. 2018 Jun;55(6):4702-4717
pubmed: 28712011
Proc Natl Acad Sci U S A. 2010 Jan 26;107(4):1666-71
pubmed: 20080590
Front Physiol. 2019 Apr 17;10:419
pubmed: 31057418
Biochem Biophys Res Commun. 2007 Aug 24;360(2):437-40
pubmed: 17601491
Gen Physiol Biophys. 2011 Dec;30(4):329-41
pubmed: 22131314
Lancet. 2019 Dec 22;392(10165):2705-2717
pubmed: 30554783
Pharmacol Res. 2022 Oct;184:106426
pubmed: 36075510
J Clin Invest. 2005 Jun;115(6):1627-35
pubmed: 15902306
Cells. 2021 Apr 13;10(4):
pubmed: 33924474
J Nat Med. 2022 Sep;76(4):765-773
pubmed: 35534765
Gut. 2016 Jul;65(7):1202-14
pubmed: 26838599
Diabetes. 2010 Jul;59(7):1817-24
pubmed: 20357365
Circulation. 2015 May 26;131(21):1861-71
pubmed: 25794851
J Pathol. 2019 May;248(1):30-40
pubmed: 30582148
Cell Rep. 2019 Mar 5;26(10):2738-2752.e4
pubmed: 30840894
Mol Cells. 2015 Dec;38(12):1037-43
pubmed: 26537193
Hepatology. 2012 Oct;56(4):1319-30
pubmed: 22531980
Hepatology. 2023 Jan 1;77(1):213-229
pubmed: 35363898
PLoS One. 2016 Jul 08;11(7):e0159191
pubmed: 27391974
Nat Med. 2021 Jul;27(7):1262-1271
pubmed: 34239138
Genes Cells. 2014 Dec;19(12):864-78
pubmed: 25270507
Clin Nutr. 2017 Jun;36(3):861-868
pubmed: 27188262
Biochim Biophys Acta Gene Regul Mech. 2018 Mar;1861(3):271-281
pubmed: 29378327
Biochim Biophys Acta. 2000 Jun 21;1492(1):203-6
pubmed: 10858549
Mol Cell Biol. 2009 Jun;29(12):3286-96
pubmed: 19364826
Eur J Pharmacol. 2013 Sep 5;715(1-3):41-5
pubmed: 23831019
Cardiovasc Res. 2022 Jan 29;118(2):489-502
pubmed: 33693480
Gastroenterology. 2014 Feb;146(2):539-49.e7
pubmed: 24184811
J Endocrinol. 2015 Mar;224(3):289-301
pubmed: 25501997
Food Funct. 2022 Nov 28;13(23):12400-12411
pubmed: 36373585

Auteurs

Ming Yang (M)

Department of Nephrology, The Second Xiangya Hospital of Central South University, Changsha, China.
Hunan Key Laboratory of Kidney Disease and Blood Purification, Changsha, Hunan, China.

Chongbin Liu (C)

Department of Nephrology, The Second Xiangya Hospital of Central South University, Changsha, China.
Hunan Key Laboratory of Kidney Disease and Blood Purification, Changsha, Hunan, China.

Na Jiang (N)

Department of Nephrology, The Second Xiangya Hospital of Central South University, Changsha, China.
Hunan Key Laboratory of Kidney Disease and Blood Purification, Changsha, Hunan, China.

Yan Liu (Y)

Department of Nephrology, The Second Xiangya Hospital of Central South University, Changsha, China.
Hunan Key Laboratory of Kidney Disease and Blood Purification, Changsha, Hunan, China.

Shilu Luo (S)

Department of Nephrology, The Second Xiangya Hospital of Central South University, Changsha, China.
Hunan Key Laboratory of Kidney Disease and Blood Purification, Changsha, Hunan, China.

Chenrui Li (C)

Department of Nephrology, The Second Xiangya Hospital of Central South University, Changsha, China.
Hunan Key Laboratory of Kidney Disease and Blood Purification, Changsha, Hunan, China.

Hao Zhao (H)

Department of Nephrology, The Second Xiangya Hospital of Central South University, Changsha, China.
Hunan Key Laboratory of Kidney Disease and Blood Purification, Changsha, Hunan, China.

Yachun Han (Y)

Department of Nephrology, The Second Xiangya Hospital of Central South University, Changsha, China.
Hunan Key Laboratory of Kidney Disease and Blood Purification, Changsha, Hunan, China.

Wei Chen (W)

Department of Nephrology, The Second Xiangya Hospital of Central South University, Changsha, China.
Hunan Key Laboratory of Kidney Disease and Blood Purification, Changsha, Hunan, China.

Li Li (L)

Department of Nephrology, The Second Xiangya Hospital of Central South University, Changsha, China.
Hunan Key Laboratory of Kidney Disease and Blood Purification, Changsha, Hunan, China.

Li Xiao (L)

Department of Nephrology, The Second Xiangya Hospital of Central South University, Changsha, China.
Hunan Key Laboratory of Kidney Disease and Blood Purification, Changsha, Hunan, China.

Lin Sun (L)

Department of Nephrology, The Second Xiangya Hospital of Central South University, Changsha, China.
Hunan Key Laboratory of Kidney Disease and Blood Purification, Changsha, Hunan, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH